ZINC AND COPPER IN CONGESTIVE-HEART-FAILURE

dc.contributor.authorATLIHAN, F
dc.contributor.authorSOYLEMEZOGLU, T
dc.contributor.authorGOKCE, A
dc.contributor.authorGUVENDIK, G
dc.contributor.authorSATICI, O
dc.date.accessioned2024-04-24T17:47:28Z
dc.date.available2024-04-24T17:47:28Z
dc.date.issued1990
dc.departmentDicle Üniversitesien_US
dc.description.abstractIn this study serum zinc (Zn) and copper (Cu) levels in children with congestive heart failure (CHF) were evaluated. The mean serum Zn levels of the patients with CHF were 92.9 +/- 18.9-mu-g/100 ml, and they showed a significant decrease when compared to controls (p < 0.05). The mean serum Cu levels, which were 173.6 +/- 26.6 mu-g/100 ml, showed a significant increase when compared to controls (p < 0.001). After digoxin therapy, a significant increase in Zn levels and a significant decrease in Cu levels were observed.en_US
dc.identifier.endpage38en_US
dc.identifier.issn0041-4301
dc.identifier.issue1en_US
dc.identifier.pmid2288016
dc.identifier.startpage33en_US
dc.identifier.urihttps://hdl.handle.net/11468/22508
dc.identifier.volume32en_US
dc.identifier.wosWOS:A1990ER99000005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTurkish J Pediatricsen_US
dc.relation.ispartofTurkish Journal of Pediatrics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCongestive Heart Failureen_US
dc.subjectZincen_US
dc.subjectCopperen_US
dc.titleZINC AND COPPER IN CONGESTIVE-HEART-FAILUREen_US
dc.titleZINC AND COPPER IN CONGESTIVE-HEART-FAILURE
dc.typeArticleen_US

Dosyalar